Related Experiment Video
Updated: Jun 12, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Regulatory T cells in tumor immunity.
Hiroyoshi Nishikawa1, Shimon Sakaguchi
1Department of Cancer Vaccine, Mie University Graduate School of Medicine, Tsu, Mie, Japan. nisihiro@clin.medic.mie-u.ac.jp
International Journal of Cancer
|June 3, 2010
Summary
Regulatory T cells (Tregs) suppress antitumor immunity. Strategies to deplete or modulate Tregs, or block their suppressive function, enhance anti-cancer responses, paving the way for combination immunotherapies.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Foxp3(+)CD25(+)CD4(+) regulatory T cells (Tregs) are crucial for maintaining immunological self-tolerance.
- Tregs play a significant role in controlling antitumor immune responses.
- High infiltration of Tregs in tumors suggests their involvement in immune suppression within the tumor microenvironment.
Purpose of the Study:
- To elucidate the role of Tregs in antitumor immunity.
- To explore strategies for enhancing antitumor immune responses by targeting Tregs.
- To evaluate the potential of combination therapies involving Treg modulation for cancer treatment.
Main Methods:
- Analysis of Treg infiltration and function in tumor tissues.
- Investigation of Treg recruitment via chemokine signaling (CCL22/CCR4).
- Assessment of the impact of Treg depletion or functional modulation on antitumor T-cell responses.
Main Results:
- Tregs infiltrate tumors and can be activated by tumor-associated antigens.
- Depletion or functional modulation of Tregs enhances both natural and vaccine-induced antitumor T-cell responses.
- Combination therapies targeting Tregs and other immune cells show synergistic antitumor activity.
Conclusions:
- Cancer vaccines targeting tumor antigens may inadvertently activate Tregs, hindering antitumor immunity.
- Strategies like Treg depletion, functional attenuation, or rendering effector T cells resistant to suppression can enhance tumor immunity.
- Combination immunotherapies targeting multiple immune components, including Tregs, represent a promising approach for anticancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...